研究者发现荷尔蒙FGF21可能扭转小鼠的脂肪肝病, Researchers find hormone FGF21 may reverse fatty liver disease in mice, offering hope for new treatments.

在细胞代谢中公布的一项新研究表明,一种名为FGF21的激素可以通过发出大脑信号和直接影响肝脏以减少脂肪和纤维化,来扭转小鼠脂肪肝病。 A new study published in Cell Metabolism shows that a hormone called FGF21 can reverse fatty liver disease in mice by signaling the brain and directly impacting the liver to reduce fat and fibrosis. 这种研究可导致对这一疾病进行新的药物治疗,影响到全球40%以上的人口。 This research could lead to new drug treatments for the condition, which affects over 40% of the global population. 目前,只有一种经批准的治疗严重脂肪性肝病的治疗方法。 Currently, there is only one approved treatment for severe cases of fatty liver disease.